# Very-Low-Density Lipoproteins Quantity but Not Composition Is Altered in Normotriglyceridemic Subjects with Elevated Lipoprotein (a) Level

**Authors:** Ewa Wieczorek-Breitzke, Martyna Feliksiak, Agnieszka Kuchta, Maciej Jankowski, Agnieszka Ćwiklińska

PMC · DOI: 10.3390/ijms27020556 · 2026-01-06

## TL;DR

In people with normal triglyceride levels but high Lp(a), VLDL particles are more numerous but not chemically different, which may still pose cardiovascular risks.

## Contribution

This study reveals that elevated Lp(a) in normotriglyceridemic individuals increases VLDL particle number without altering composition.

## Key findings

- Individuals with Lp(a) ≥ 30 mg/dL had significantly higher VLDL concentrations of triglycerides, cholesterol, and apolipoproteins.
- VLDL particle composition remained unchanged, suggesting increased particle number rather than altered composition.
- Redistribution of lipids and apolipoproteins toward VLDL may contribute to residual cardiovascular risk.

## Abstract

Cardiovascular disease (CVD) is influenced by disturbances in lipoprotein composition and metabolism, including triglyceride-rich lipoproteins (TRLs) and elevated lipoprotein (a) (Lp(a)). While interactions between Lp(a) and very-low-density lipoproteins (VLDL) have been studied in hypertriglyceridemic and CVD populations, data in normotriglyceridemic individuals without CV events are limited. Seventy normotriglyceridemic adults with triglycerides < 150 mg/dL and no CV events were enrolled and divided into two groups based on Lp(a) concentration: <30 mg/dL and ≥30 mg/dL. VLDL was isolated by ultracentrifugation, and concentrations of Lp(a), lipids (triglycerides, cholesterol), and apolipoproteins (apo B, apo C-II, apo C-III, apo E) were measured in serum and VLDL. Serum lipid and apolipoprotein concentrations did not differ between the groups. Individuals with Lp(a) ≥ 30 mg/dL had significantly higher VLDL concentrations of triglycerides (+71%), cholesterol (+54%), apo B (+28%), apo C-II (+36%), and apo C-III (+33%). Ratios of lipids and apolipoproteins to apo B indicated unchanged VLDL particle composition, suggesting that differences reflected increased particle number rather than altered composition. In normotriglyceridemic subjects with Lp(a) ≥ 30 mg/dL, VLDL particles are more abundant but compositionally unchanged. Redistribution of lipids and apolipoproteins toward VLDL may contribute to VLDL residual cardiovascular risk, underscoring the need for further studies on VLDL-Lp(a) interactions.

## Linked entities

- **Proteins:** LPA (lipoprotein(a)), APOB (apolipoprotein B), APOC2 (apolipoprotein C2), APOC3 (apolipoprotein C3), APOE (apolipoprotein E)
- **Diseases:** Cardiovascular disease (MONDO:0004995)

## Full-text entities

- **Genes:** APOB (apolipoprotein B) [NCBI Gene 338] {aka FCHL2, FLDB, LDLCQ4, apoB-100, apoB-48}, APOC3 (apolipoprotein C3) [NCBI Gene 345] {aka APOCIII, Apo-C3, ApoC-3}, APOE (apolipoprotein E) [NCBI Gene 348] {aka AD2, APO-E, ApoE4, LDLCQ5, LPG}, LPA (lipoprotein(a)) [NCBI Gene 4018] {aka AK38, APOA, LP}, APOC2 (apolipoprotein C2) [NCBI Gene 344] {aka APO-CII, APOC-II}
- **Diseases:** CVD (MESH:D002318), hypertriglyceridemic (MESH:D064250)
- **Chemicals:** cholesterol (MESH:D002784), triglyceride (MESH:D014280), lipid (MESH:D008055)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12841498/full.md

---
Source: https://tomesphere.com/paper/PMC12841498